Home / Guides / Best EHR for longevity clinics

Buyer's guide · 2026

The best EHR for longevity clinics in 2026

Published July 4, 2026 · Updated July 22, 2026 · 12-minute read · By the CareOS team — builders of practice software for longevity, hormone, and functional medicine. Yes, we sell one of the platforms below; the criteria are useful even if you never consider ours.

Short answer: the best EHR for a longevity clinic is built around protocols, biomarkers, and memberships — not insurance claims. In 2026 that means: CareOS if you want all three native plus multi-state compliance; Cerbo if you need claims and accept heavy configuration; Healthie or Practice Better if you're coaching-led; OptiMantra if you want a broad integrative toolkit with insurance billing.

Why this decision is different in 2026

The longevity clinic market reached roughly $6 billion in 2026, growing 12.5% annually, with clinic headcount growing 37% year over year — the fastest of any category in the longevity economy (Research and Markets; Skytale Group market intelligence, 2026). Meanwhile 30 million Americans are on GLP-1 therapy, and that care is consolidating into clinically guided programs pairing medication with resistance training, protein targets, peptides, and hormone optimization (PwC GLP-1 trends analysis, 2026).

Almost none of the software this market runs on was designed for it. Most longevity practices operate on an EHR built for insurance medicine or talk therapy, plus spreadsheets for protocols, a separate membership tool, and a compliance tracker someone maintains by hand. The switching wave now underway is practices consolidating that stack.

The 7 capabilities that actually matter

1. A real protocol engine

Titration schedules (GLP-1s, peptides, HRT) with dose steps, hold conditions, monitoring requirements, contraindication checks, and an immutable administration log. If the vendor's answer is "custom fields" or "note templates," that's a workaround, not a capability. This is the single sharpest differentiator between generalist and purpose-built platforms.

2. Biomarkers judged against optimal — not just reference — ranges

Longevity medicine's product is the trend toward optimal. Your EHR should trend every marker longitudinally against your practice's optimal targets and show patients the trajectory. Reference-range-only lab views are a red flag.

3. Membership and program billing as first-class features

Recurring memberships, multi-week programs, package redemption, deposits, and superbills. If recurring revenue lives in a separate tool, you'll reconcile two systems forever and your churn data will always be stale.

4. Wearable and CGM data in the chart

Oura, Whoop, and CGM streams belong next to labs. In 2026 this moved from differentiator to expectation — biological-age tracking and continuous data are now standard patient expectations at premium clinics.

5. Controlled-substance compliance that gates, not logs

TRT and ketamine are Schedule III. Multi-state telehealth means per-state DEA and PDMP obligations per provider. The difference that matters: does the system merely record licenses, or does it block a booking or prescription where the provider isn't eligible? Passive trackers fail exactly when you're growing fastest.

6. AI charting drafted from clinical context

Generic AI scribes transcribe conversations. The useful version drafts from the active protocol, latest labs, and patient check-ins — then keeps the clinician as author of record. Ask vendors what context their AI sees, not whether they "have AI."

7. Fast evaluation and migration clarity

If you can't evaluate the product on real workflows, or leaving requires a data ransom, keep walking. Modern vendors offer a live demo, guided workflow mapping, and structured export. Your data is yours.

The platforms, honestly compared

Full feature-by-feature table on our comparison page.

Pricing benchmarks (verified June 2026, re-checked July 2026)

Expect $99–$300 per provider per month for a serious platform. Below $50, you're buying a coaching tool and will pay the difference in spreadsheets and add-ons. Above $250, you should be getting either claims infrastructure (Cerbo) or compliance automation (CareOS Scale). Watch for per-patient fees, charged admin seats, and paid migrations — the three quiet multipliers.

The switching checklist

  1. Export everything from your current system before giving notice (patients, notes, documents, lab history).
  2. Run a 2-week parallel evaluation with 5–10 real (consented) patient workflows — including one full protocol cycle.
  3. Migrate templates first; protocol and note templates determine 80% of daily feel.
  4. Confirm the new vendor migrates for free and in writing (CareOS does, on every plan).
  5. Cut over on a Monday after a light week; keep read-only access to the old system for 90 days.

Bottom line

Ask one question of every vendor: "Show me a GLP-1 titration with a hold condition, a biomarker trending toward an optimal range, and what happens when a provider's license lapses." The demos that answer it in the product — not in a roadmap slide — are your shortlist. We built CareOS so that demo takes ninety seconds; see it yourself or create your workspace in two minutes.

Market data: Research and Markets Longevity Clinic Market Report 2026; Skytale Group Market Intelligence (2026); PwC GLP-1 business model analysis (2026). Competitor pricing from public pricing pages and third-party reviews (Software Finder, EMRSystems), June 2026 — corrections welcome through the setup form.

See the ninety-second demo

A GLP-1 titration with hold conditions, a biomarker trending to optimal, and a license lapse blocking a booking — live in the product.